Physician profile
Leo Marcoff
NPI 1407935398
$15,080.72
in general payments reported to CMS, 2019-2025
8 companies · $1,680 in 2025
The $1,680 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,069 · 2020: $2,103 · 2021: $1,378 · 2022: $904 · 2023: $534 · 2024: $2,413 · 2025: $1,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,627.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $12,058.70 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Medtronic, INC. | $1,546.97 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,140.02 | 2019-2025 | Epic, Navitor, Mitraclip |
| Boston Scientific Corporation | $161.41 | 2021-2024 | Watchman Flx |
| Heartflow, INC. | $68.70 | 2019 | |
| Medtronic Vascular, INC. | $59.54 | 2020 | |
| Abiomed | $28.42 | 2019 | |
| Pfizer INC. | $16.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Marcoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.